There are currently over 800 hemoglobin variants catalogued, of which approximately 300 are due to mutations in the alpha-globin gene. In addition, approximately 5% of alpha-thalassemia is caused by point mutations. This test, which sequences the coding regions and introns of both the alpha-globin 1 (HBA1) and alpha-globin 2 (HBA2) genes in both directions, identifies hemoglobin variants that are not easily diagnosed by electrophoresis/HPLC and can determine the cause of non-deletional alpha-thalassemia.
Indications for testing include:
NOTE: For outside patients please provide additional clinical and family history. Please include the following available laboratory data: CBC, Hb electrophoresis, and iron studies.
Notes: To order testing for a relative of an individual with a known alpha-globin mutation, see the Laboratory Medicine Online Test Guide for Alpha Hemoglobin Sequencing, Relative [HAREL]. If testing for deletional alpha-thalassemia is indicated, order “Alpha Thalassemia DNA Screen”.
Code | Name |
---|---|
HASRES | Hb alpha Results |
HASCI | Hb alpha Clinical Information |
HASINT | Hb alpha Interpretation |
HASMTH | Hb alpha Method |
DNA sequencing of the coding regions and introns of both the alpha1 (HBA1) and alpha 2 globin (HBA2) genes in both directions to detect point mutations causing alpha globin variants and some types of alpha thalassemia.
This test detects alpha globin variants and non-deletional alpha thalassemia mutations (e.g. Hb Constant Spring). The coding regions and introns of both HBA1 and HBA2 genes are sequenced in bidirectionally. The reference mRNA sequences are HBA1 (NM_000558.3) and HBA2 (NM_000517.4) with nucleotide 1 corresponding to the A of the AUG initiation codon (nucleotide 38 of both reference sequences) and codon 1 corresponding to the valine encoded by GTG (nucleotides 41-43 of both reference sequences). The sensitivity of this test for detecting nucleotide substitutions, small insertions and deletions and in the alpha 1 (HBA1) and alpha 2 (HBA2) genes is theoretically >98%. This test will not detect mutations that lie outside of the sequenced regions, nor large HBA1 and HBA2 gene deletions (e.g. –a3.7, – –SEA). This test was developed and its performance characteristics determined by the Department of Laboratory Medicine at the University of Washington.
No mutation detected.
Acceptable:
Unacceptable: Heparin green top tubes, buccal swab
SPS specimen handling:
If fetal tissue (cultured amniocytes or chorionic villi) was received for prenatal testing, consultation with the laboratory is required. Please notify the Genetics lab about prenatal studies via email at geneticshelp@uw.edu or call 206-598-7021.
For clients outside of UW, please include the most recent CBC and Hb electrophoresis result/s (if available), and/or any relevant clinical history.
UW-MT |
Genetics
Attention: Genetics Lab Tel: 206-598–6429 M–F (7:30 AM–4:00 PM) Tel (EXOME only): 206-543-0459 |
Faculty |
---|
For pricing information, contact Client Support Services 206-520-4600 or 800-713-5198.